Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26 20:00 | 3/4/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | 3 | S.d | -2,208 | 74.35 | 0 | -30 | 213 | D | |||||||||||||||
3/4/26 20:00 | 3/2/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | CFO | 4 | S.dm | -1,001 | 74.16 | 0 | -14 | 193 | D | |||||||||||||||
2/13/26 20:00 | 2/11/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | MA | DO | CEO | 2 | S | -2,889 | 72.23 | 0 | -40 | 1,193 | D | |||||||||||||||
1/22/26 20:07 | 1/22/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Fairmount Funds Management LLC | PA | D | 1 | S.d | -133,525 | 76.30 | 0 | -1,750 | 401 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |